Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
QURE uniQure NV
- Stocks
- Healthcare
- NASDAQ: QURE
Price (delayed)
$12.95
Market cap
$708.99M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.39
Enterprise value
$1B
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline
Highlights
The gross margin has soared by 67% since the previous quarter
The company's EPS rose by 29% YoY and by 11% QoQ
The company's revenue fell by 26% QoQ but it rose by 6% YoY
The debt fell by 5% YoY but it rose by 2.4% QoQ
The equity has shrunk by 77% YoY
Key stats
What are the main financial stats of QURE
Market
Valuations
Earnings
Shares outstanding
54.75M
Market cap
$708.99M
Enterprise value
$1B
Price to earnings (P/E)
N/A
Price to book (P/B)
20.79
Price to sales (P/S)
34.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.73
Revenue
$20.2M
Gross profit
$10.9M
Operating income
-$169.4M
Net income
-$217.58M
EBIT
-$152.55M
EBITDA
-$138.01M
Free cash flow
-$175.72M
Per share
Balance sheet
Liquidity
EPS
-$4.39
EPS diluted
-$4.39
Free cash flow per share
-$3.31
Book value per share
$0.62
Revenue per share
$0.38
TBVPS
$9.6
Total assets
$605.4M
Total liabilities
$571.72M
Debt
$512.86M
Equity
$33.69M
Working capital
$399.11M
Debt to equity
15.22
Current ratio
11.99
Quick ratio
11.33
Net debt/EBITDA
-2.14
Margins
Efficiency
Dividend
EBITDA margin
-683.2%
Gross margin
54%
Net margin
-1,077.1%
Operating margin
-838.6%
Return on assets
-34.3%
Return on equity
-483.9%
Return on invested capital
-19.9%
Return on capital employed
-26.8%
Return on sales
-755.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QURE stock price
How has the uniQure stock price performed over time
Intraday
1.25%
1 week
-18.5%
1 month
45.02%
1 year
163.21%
YTD
-26.67%
QTD
22.17%
Financial performance
How have uniQure's revenue and profit performed over time
Revenue
$20.2M
Gross profit
$10.9M
Operating income
-$169.4M
Net income
-$217.58M
Gross margin
54%
Net margin
-1,077.1%
The gross margin has soared by 67% since the previous quarter
The operating margin has grown by 39% YoY but it has contracted by 23% from the previous quarter
QURE's operating income is up by 36% YoY and by 8% QoQ
The net margin rose by 31% YoY but it fell by 22% QoQ
Price vs fundamentals
How does QURE's price correlate with its fundamentals
Growth
What is uniQure's growth rate over time
Valuation
What is uniQure stock price valuation
P/E
N/A
P/B
20.79
P/S
34.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.73
The company's EPS rose by 29% YoY and by 11% QoQ
The equity has shrunk by 77% YoY
The P/S is 77% higher than the last 4 quarters average of 19.0 but 26% lower than the 5-year quarterly average of 45.2
The company's revenue fell by 26% QoQ but it rose by 6% YoY
Efficiency
How efficient is uniQure business performance
The return on equity has declined by 48% since the previous quarter
The company's return on sales rose by 40% YoY but it fell by 18% QoQ
The return on invested capital has increased by 23% year-on-year and by 8% since the previous quarter
The ROA has grown by 3.1% from the previous quarter
Dividends
What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QURE.
Financial health
How did uniQure financials performed over time
QURE's total assets is 6% greater than its total liabilities
The current ratio has grown by 28% YoY and by 23% from the previous quarter
The quick ratio is up by 27% year-on-year and by 22% since the previous quarter
The debt to equity has soared by 121% from the previous quarter
The equity has shrunk by 77% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.